
Revolutionizing Type 1 Diabetes Prevention: AdventHealth Translational Research Institute's Breakthrough Screening Effort
The FDA's approval of Teplizumab has ushered in a new era in diabetes management. This medication promises to slow down the progression of Type 1 diabetes, offering a glimmer of hope to individuals...